New York State Common Retirement Fund Zynerba Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$3.31 - $6.54 $14,895 - $29,430	-4,500 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$5.61 - $8.57 $94,248 - $143,976	-16,800 Reduced 78.87%	4,500 $27,000
Q2 2019 Aug 09, 2019	BUY	$5.4 - $15.5 $115,020 - $330,150	21,300 New	21,300 $289,000
Q2 2018 Aug 10, 2018	SELL	$7.98 - $12.39 $97,356 - $151,158	-12,200 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	12,200	12,200 $207,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.